Cargando…

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma

Cancer stem cells (CSCs) are considered to be the origin of ovarian cancer (OC) development, recurrence, and chemoresistance. We investigated changes in expression levels of the CSC biomarker, cluster of differentiation 133 (CD133), from primary OC cell lines to induction of CSC-spheres in an attemp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chao Lien, Chen, Ying Jen, Fan, Ming Huei, Liao, Yi Jen, Mao, Tsui Lien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554888/ https://www.ncbi.nlm.nih.gov/pubmed/32899775 http://dx.doi.org/10.3390/ijms21186467

Ejemplares similares

LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment
por: Mao, Tsui-Lien, et al.
Publicado: (2021)

Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth
por: Mao, Tsui Lien, et al.
Publicado: (2019)

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006)

The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
por: Liu, Chao-Lien, et al.
Publicado: (2021)

Autocrine interleukin-23 promotes self-renewal of CD133(+) ovarian cancer stem-like cells
por: Wang, Dan, et al.
Publicado: (2016)

A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers
por: Lee, Yi-Jen, et al.
Publicado: (2016)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
por: Hu, L, et al.
Publicado: (2010)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features
por: Argaw-Denboba, Ayele, et al.
Publicado: (2017)

CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma
por: Zhong, Zhi-Yong, et al.
Publicado: (2018)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
por: Walter, Dagmar, et al.
Publicado: (2011)

CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
por: Roy, Lynn, et al.
Publicado: (2018)

Role of CD133(+) cells in tongue squamous carcinomas: Characteristics of ‘stemness’ in vivo and in vitro
por: Wang, Kai, et al.
Publicado: (2016)

Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer
por: Yang, Ching-Yao, et al.
Publicado: (2020)

CD133(+) ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
por: Long, Haixia, et al.
Publicado: (2015)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
por: Ding, Bi-Sen, et al.
Publicado: (2013)

An emerging role of CD9 in stemness and chemoresistance
por: Ullah, Mujib, et al.
Publicado: (2019)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells?
por: Virant-Klun, Irma, et al.
Publicado: (2019)

Label-free quantitative proteomics of CD133-positive liver cancer stem cells
por: Tsai, Sheng-Ta, et al.
Publicado: (2012)

Volume-activated chloride channel exists in CD133+ lung cancer stem cells
por: Mao, Z, et al.
Publicado: (2013)

Silencing of Btbd7 Inhibited Epithelial–Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells
por: Fang, Li-Zhou, et al.
Publicado: (2017)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties
por: Park, Jimin, et al.
Publicado: (2022)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
por: Min, Kyung-Jin, et al.
Publicado: (2012)

CD133(+)CD24(lo) defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
por: Paschall, Amy V., et al.
Publicado: (2016)

TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
por: Nuti, Sudhakar V., et al.
Publicado: (2014)

Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
por: Li, Shan-Shan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9v2qfbg7mo6vecp6qaqlrvir5m